New Zealand: Kiwi scientists work on world-first herpes vaccine for Pacific oysters to help industry recover

Published 2024년 6월 10일

Tridge summary

Scientists at Nelson's Cawthron Institute in New Zealand are leading a team in developing a world-first vaccine to protect oysters from a deadly herpes virus, following a breakthrough in understanding shellfish immune memory. The project, funded by the Government's Endeavour Fund, has successfully identified 10 potential vaccine candidates from 45 options and is now testing their effectiveness. The vaccine, which could also benefit other shellfish, is being developed by feeding the vaccine to young oysters through algae. The race is on to create the first shellfish vaccine, with similar research ongoing in France.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Kiwi scientists are developing a world-first vaccine to protect oysters against a deadly disease that has crippled our multi-million-dollar industry. Pacific oyster farmers have been struggling to stay afloat since the herpes virus began killing the shellfish in 2010, wiping out about 70 percent of their stock. But now, help is finally on the horizon. Previously, a vaccine was thought impossible for shellfish, and then a breakthrough was made. "Very recently, research revealed that shellfish can have an immune memory, so when exposed one time to a pathogen they respond better a second time," said shellfish physiologist Lizenn Delisle. The discovery has opened the door for scientists to develop a vaccine. Earlier this year Nelson's Cawthron Institute was granted $1 million over three years from the Government's Endeavour Fund to create a practical vaccine. Delisle and her colleague Julien Vignier are leading the project. They've just finished phase one, where they screened 45 ...
Source: Newshub

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.